Clinical trial for Psychosis;Schizophrenic
Official title Seven-step Phenomenological Psychotherapy for Self-disorder - a Pilot Study
ClinicalTrials.gov ID: NCT06597864
What this study is testing
- What it's testing
- The study aims to learn how adults with schizophrenia or other non‑affective psychotic disorders experience this new therapy. It gathers participants' views on how helpful it felt and any changes in self‑experience.
- Who it's for
- Adults diagnosed with schizophrenia, other non‑affective psychotic disorders, or at risk for psychosis.
- What's involved
- Participants receive the seven‑step phenomenological psychotherapy and, after treatment, are interviewed about how they liked it, whether it seemed useful, and any changes in how they experience themselves and relationships.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 39
You may be able to join if
- Clinical diagnoses in the ICD-10-CM Code range, i.e. schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders.
- Or Psychosis risk syndrome as defined in the Structured Interview of Psychosis-Risk Syndromes (SIPS) (McGlashan, Walsh, \& Woods, 2010)
- Present with anomalous self-experiences, as confirmed by the Screen Questionnaire for EASE (SQuEASE-6) (Møller, 2018)
- Motivated to explore and work with anomalous self-experiences in psychotherapy
You likely can't join if
- Severe, ongoing psychosis
- Severe, ongoing drug abuse
- IQ\<70
- Poor Norwegian language profiency
The study team makes the final eligibility decision.
Where it is enrolling
- Sandvika, Bærum, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 39 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Sandvika, Bærum, Norway. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.